8 September 2023
Directa Plus plc
("Directa Plus" or the "Company")
Notice of Interim Results and Investor Presentations
Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, confirms it expects to announce its results for the six months ended 30 June 2023 on Wednesday, 27 September 2023. In addition, management will host a live virtual presentation and Q&A for analysts at 10a.m. on the morning of publication of the results and a live virtual presentation and Q&A for retail investors on Friday, 29 September 2023 at 11a.m. on the Investor Meet Company platform.
Both presentations will be given by Giulio Cesareo, Chief Executive Officer, and Giorgio Bonfanti, Chief Financial Officer.
Questions can be submitted at any time during the live presentations.
A recording of the presentation will be made available on the Company's website following the conclusion of the investor presentation.
Analyst Presentation
To register to attend, please email directaplus@almapr.co.uk
Retail Investor Presentation
To register to attend, please do so here
Directa Plus plc Giulio Cesareo, CEO Giorgio Bonfanti, CFO
| +39 02 36714458
|
Cenkos Securities plc (Nominated Adviser and Joint Broker) Neil McDonald Adam Rae
| +44 131 220 6939 |
Singer Capital Markets Securities Limited (Joint Broker) Rick Thompson Phil Davies
| +44 20 7496 3069 |
Alma PR (Financial PR Adviser) Justine James Hannah Campbell Kinvara Verdon | +44 20 3405 0205 directaplus@almapr.co.uk |
Notes to Editors
Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.
This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products.
Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+(R)) have multiple applications due to its properties. These G+(R) products can be categorised into various families, with different products being suitable for specific practical applications.
Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. Directa Plus holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.